Aspen raises dividend hopes as it slashes debt and boosts cash flow
Among the winners during the Covid-19 pandemic, the company cuts debt to within its target range and delivers strong operational cash flow
27 August 2020 - 12:51
UPDATED 27 August 2020 - 23:44
Aspen Pharmacare slashed its debt mountain and delivered stronger cash flow in financial 2020, reaping the benefits of the stockpiling of everyday essentials by locked-down consumers and raising hopes that it could reopen its dividend taps in coming years.
Aspen, which also operates in several African countries, Australia and Latin America, has been among the winners at a time when the worldwide focus on fighting the Covid-19 pandemic saw a reduction in demand for treatment of other communicable diseases...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.